Publikation: Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
DOI (zitierfähiger Link)
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
Animal studies for embryotoxicity evaluation of potential therapeutics and environmental factors are complex, costly, and time-consuming. Often, studies are not of human relevance because of species differences. In the present study, we recapitulated the process of cardiomyogenesis in human induced pluripotent stem cells (hiPSCs) by modulation of the Wnt signaling pathway to identify a key cardiomyogenesis gene signature that can be applied to identify compounds and/or stress factors compromising the cardiomyogenesis process. Among the 23 tested teratogens and 16 non-teratogens, we identified three retinoids including 13- cis -retinoic acid that completely block the process of cardiomyogenesis in hiPSCs. Moreover, we have identified an early gene signature consisting of 31 genes and associated biological processes that are severely affected by the retinoids. To predict the inhibitory potential of teratogens and non-teratogens in the process of cardiomyogenesis we established the “Developmental Cardiotoxicity Index” (CDI 31g ) that accurately differentiates teratogens and non-teratogens to do or do not affect the differentiation of hiPSCs to functional cardiomyocytes.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
CHERIANIDOU, Anna, Franziska KAPPENBERG, Florian SEIDEL, Aviseka ACHARYA, Panagiota PAPAZOGLOU, Sureshkumar Perumal SRINIVASAN, Jürgen HESCHELER, Luying PENG, Marcel LEIST, Agapios SACHINIDIS, 2023. Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells. In: Cell Death Discovery. Springer. 2023, 9(1), 321. eISSN 2058-7716. Available under: doi: 10.1038/s41420-023-01616-6BibTex
@article{Cherianidou2023-08-29Trans-67827, year={2023}, doi={10.1038/s41420-023-01616-6}, title={Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells}, number={1}, volume={9}, journal={Cell Death Discovery}, author={Cherianidou, Anna and Kappenberg, Franziska and Seidel, Florian and Acharya, Aviseka and Papazoglou, Panagiota and Srinivasan, Sureshkumar Perumal and Hescheler, Jürgen and Peng, Luying and Leist, Marcel and Sachinidis, Agapios}, note={Article Number: 321} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/67827"> <dc:rights>Attribution 4.0 International</dc:rights> <dcterms:abstract>Animal studies for embryotoxicity evaluation of potential therapeutics and environmental factors are complex, costly, and time-consuming. Often, studies are not of human relevance because of species differences. In the present study, we recapitulated the process of cardiomyogenesis in human induced pluripotent stem cells (hiPSCs) by modulation of the Wnt signaling pathway to identify a key cardiomyogenesis gene signature that can be applied to identify compounds and/or stress factors compromising the cardiomyogenesis process. Among the 23 tested teratogens and 16 non-teratogens, we identified three retinoids including 13- cis -retinoic acid that completely block the process of cardiomyogenesis in hiPSCs. Moreover, we have identified an early gene signature consisting of 31 genes and associated biological processes that are severely affected by the retinoids. To predict the inhibitory potential of teratogens and non-teratogens in the process of cardiomyogenesis we established the “Developmental Cardiotoxicity Index” (CDI 31g ) that accurately differentiates teratogens and non-teratogens to do or do not affect the differentiation of hiPSCs to functional cardiomyocytes.</dcterms:abstract> <dc:creator>Sachinidis, Agapios</dc:creator> <dc:contributor>Seidel, Florian</dc:contributor> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/67827"/> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2023-09-20T08:07:51Z</dc:date> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dc:contributor>Srinivasan, Sureshkumar Perumal</dc:contributor> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2023-09-20T08:07:51Z</dcterms:available> <dc:creator>Seidel, Florian</dc:creator> <dc:creator>Hescheler, Jürgen</dc:creator> <dc:contributor>Kappenberg, Franziska</dc:contributor> <dc:creator>Cherianidou, Anna</dc:creator> <dc:contributor>Sachinidis, Agapios</dc:contributor> <dcterms:issued>2023-08-29</dcterms:issued> <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/> <dc:contributor>Acharya, Aviseka</dc:contributor> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:contributor>Peng, Luying</dc:contributor> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/67827/1/Cherianidou_2-1l0sbytpsslu26.pdf"/> <dc:contributor>Hescheler, Jürgen</dc:contributor> <dc:creator>Peng, Luying</dc:creator> <dcterms:title>Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells</dcterms:title> <dc:creator>Leist, Marcel</dc:creator> <dc:creator>Kappenberg, Franziska</dc:creator> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/67827/1/Cherianidou_2-1l0sbytpsslu26.pdf"/> <dc:creator>Srinivasan, Sureshkumar Perumal</dc:creator> <dc:contributor>Cherianidou, Anna</dc:contributor> <dc:creator>Acharya, Aviseka</dc:creator> <dc:language>eng</dc:language> <dc:creator>Papazoglou, Panagiota</dc:creator> <dc:contributor>Papazoglou, Panagiota</dc:contributor> <dc:contributor>Leist, Marcel</dc:contributor> </rdf:Description> </rdf:RDF>